找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cardiac Considerations in Chronic Lung Disease; Surya P. Bhatt Book 2020 Springer Nature Switzerland AG 2020 chronic lung disease.COPD.chr

[復制鏈接]
樓主: Colossal
31#
發(fā)表于 2025-3-26 23:07:13 | 只看該作者
32#
發(fā)表于 2025-3-27 04:12:53 | 只看該作者
Pathophysiology of Cardiovascular Disease in Chronic Lung Disease,isk factors including smoking and socioeconomic status, there is now growing evidence to suggest potential causality between CLD and CVD rather than simple association. In this chapter, we will review the pathobiologic processes that may drive the development of CVD in patients with CLD.
33#
發(fā)表于 2025-3-27 08:01:34 | 只看該作者
Pathophysiology of Right Heart Disease in Chronic Lung Disease,hronic lung disease is complex, and mechanisms include pulmonary hypertension, hypoxia, neurohormonal alterations, metabolic perturbations, endothelial dysfunction, ischemia, and systemic inflammation. The right ventricle can develop adaptive or maladaptive responses to these processes, and varying
34#
發(fā)表于 2025-3-27 12:38:37 | 只看該作者
Pulmonary Hypertension Associated with Chronic Lung Diseases: Treatment Considerations,ng mean pulmonary arterial pressure?>20?mmHg during right heart catheterization (RHC). The most common chronic lung conditions that cause PH are chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), but PH can occur in the context of other parenchymal lung diseases in
35#
發(fā)表于 2025-3-27 14:27:23 | 只看該作者
36#
發(fā)表于 2025-3-27 19:47:19 | 只看該作者
Physiology of Heart-Lung Interactions,g work closely together to achieve these ends. Because the heart and lung share volume and pressures within the thorax, each system tends to alter the other, especially when there is preexisting heart or lung disease, or when challenged by rising demand. Cardiopulmonary interactions are mediated by
37#
發(fā)表于 2025-3-27 23:11:42 | 只看該作者
Medication Safety in Chronic Lung Disease with Cardiac Comorbidity,ation efficacy and safety in these patients is complicated by interrelationships among aging, frequent healthcare encounters, polypharmacy, alterations in drug disposition related to heart disease, aerosol drug delivery, drug interactions, and heightened risks of adverse-effects. In addition to side
38#
發(fā)表于 2025-3-28 02:23:23 | 只看該作者
Cardiovascular Co-Morbidity in Chronic Lung Disease: Exercise Training,e organised according to specialty, this is a slight misnomer as the main benefits of both services occur via the systemic features of the conditions. There is therefore a need to consider how services are organised for patients to maximise benefit both in terms of access and in receiving a tailored
39#
發(fā)表于 2025-3-28 08:02:21 | 只看該作者
40#
發(fā)表于 2025-3-28 13:04:03 | 只看該作者
Lung Transplantation for Chronic Lung Disease: Cardiac Considerations,gement, and immunosuppressive strategies have resulted in better long-term post-transplant outcomes. However, careful candidate selection, including a thorough assessment of cardiac function, is essential for optimizing the likelihood of survival while awaiting transplantation, and improving the cha
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-2-2 01:42
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
凌云县| 台东县| 新安县| 桂林市| 永靖县| 临泽县| 长垣县| 砀山县| 苏尼特右旗| 金阳县| 韶山市| 阳西县| 昌吉市| 松江区| 逊克县| 威海市| 吉安县| 社旗县| 彭州市| 尼勒克县| 灵川县| 建瓯市| 淄博市| 湖口县| 琼结县| 龙泉市| 麻栗坡县| 枝江市| 海原县| 青浦区| 清新县| 册亨县| 卢湾区| 深圳市| 泸水县| 谢通门县| 新晃| 辛集市| 康马县| 紫金县| 竹北市|